Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
XL019 is a potent, bioavailable JAK inhibitor with preference for JAK2 (IC50 = 2 nM) over JAK1 and JAK3 (IC50s = 130 and 250 nM, respectively).1,2 It is effective against JAK2V617F as well as JAK2 and inhibits phosphorylation of STAT5 in vivo.3
WARNING This product is not for human or veterinary use.
1. SAR and in vivo evaluation of 4-
2. Therapeutic potential of JAK2 inhibitors. Hematology Am. Soc. Hematol. Educ. Program 636-642 (2009).
3. Dysregulation of JAK-